Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Temporal trends, safety, and efficacy of bivalirudin in elective percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
Gurm HS, Smith DE, Chetcuti SJ, Share D, Khanal S, Riba A, Carter AJ, Lalonde T, Kline-Rogers E, O'Donnell M, O'Neill W, Safian R, Moscucci M; Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Gurm HS, et al. Among authors: riba a. J Interv Cardiol. 2007 Jun;20(3):197-203. doi: 10.1111/j.1540-8183.2007.00262.x. J Interv Cardiol. 2007. PMID: 17524111 Free article. Clinical Trial.
Impact of worsening renal dysfunction on the comparative efficacy of bivalirudin and platelet glycoprotein IIb/IIIa inhibitors: insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
Perdoncin E, Zhang M, Riba A, LaLonde TA, Grines CL, Gurm HS. Perdoncin E, et al. Among authors: riba a. Circ Cardiovasc Interv. 2013 Dec;6(6):688-93. doi: 10.1161/CIRCINTERVENTIONS.113.000554. Epub 2013 Nov 26. Circ Cardiovasc Interv. 2013. PMID: 24280966
Safety of contemporary percutaneous peripheral arterial interventions in the elderly insights from the BMC2 PVI (Blue Cross Blue Shield of Michigan Cardiovascular Consortium Peripheral Vascular Intervention) registry.
Plaisance BR, Munir K, Share DA, Mansour MA, Fox JM, Bove PG, Riba AL, Chetcuti SJ, Gurm HS, Grossman PM; BMC2 PVI (Blue Cross Blue Shield of Michigan Cardiovascular Consortium Peripheral Vascular Intervention). Plaisance BR, et al. Among authors: riba al. JACC Cardiovasc Interv. 2011 Jun;4(6):694-701. doi: 10.1016/j.jcin.2011.03.012. JACC Cardiovasc Interv. 2011. PMID: 21700256 Free article.
The relative safety and efficacy of abciximab and eptifibatide in patients undergoing primary percutaneous coronary intervention: insights from a large regional registry of contemporary percutaneous coronary intervention.
Gurm HS, Smith DE, Collins JS, Share D, Riba A, Carter AJ, LaLonde T, Kline-Rogers E, O'Donnell M, Changezi H, Zughaib M, Safian R, Moscucci M; Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Gurm HS, et al. Among authors: riba a. J Am Coll Cardiol. 2008 Feb 5;51(5):529-35. doi: 10.1016/j.jacc.2007.09.053. J Am Coll Cardiol. 2008. PMID: 18237680 Free article.
Retroperitoneal hematoma after percutaneous coronary intervention: prevalence, risk factors, management, outcomes, and predictors of mortality: a report from the BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) registry.
Trimarchi S, Smith DE, Share D, Jani SM, O'Donnell M, McNamara R, Riba A, Kline-Rogers E, Gurm HS, Moscucci M; BMC2 Registry. Trimarchi S, et al. Among authors: riba a. JACC Cardiovasc Interv. 2010 Aug;3(8):845-50. doi: 10.1016/j.jcin.2010.05.013. JACC Cardiovasc Interv. 2010. PMID: 20723857 Free article.
99 results